Get the Stockscreener App
126.10
0.53%
-0.67
After Hours:
126.00
-0.10
-0.08%
Xylem Inc stock is traded at $126.10, with a volume of 2.99M.
It is down -0.53% in the last 24 hours and down -9.33% over the past month.
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $9 billion in revenue in 2025.
See More
Previous Close:
$126.77
Open:
$127.94
24h Volume:
2.99M
Relative Volume:
2.02
Market Cap:
$30.72B
Revenue:
$9.03B
Net Income/Loss:
$950.00M
P/E Ratio:
32.15
EPS:
3.9218
Net Cash Flow:
$873.00M
1W Performance:
-9.44%
1M Performance:
-9.33%
6M Performance:
-12.08%
1Y Performance:
-2.93%
1-Day Range:
$126.08
$129.71
1-Week Range:
$123.98
$142.97
52-Week Range:
$100.47
$154.27
Xylem Inc Stock (XYL) Company Profile
Name
Xylem Inc
Sector
Industry
Phone
202-869-9150
Address
301 WATER STREET SE, WASHINGTON, NY
Compare XYL vs GEV, ETN, PH, ITW, EMR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XYL
Xylem Inc
|
126.10 | 30.88B | 9.03B | 950.00M | 873.00M | 3.9218 |
|
GEV
Ge Vernova Inc
|
816.56 | 222.00B | 38.06B | 4.88B | 3.71B | 17.79 |
|
ETN
Eaton Corporation Plc
|
390.33 | 153.84B | 27.45B | 4.09B | 3.32B | 10.46 |
|
PH
Parker Hannifin Corp
|
982.21 | 125.69B | 20.46B | 3.54B | 3.34B | 27.42 |
|
ITW
Illinois Tool Works Inc
|
298.51 | 86.47B | 16.04B | 3.07B | 2.85B | 10.49 |
|
EMR
Emerson Electric Co
|
144.98 | 86.92B | 18.18B | 2.25B | 2.58B | 4.0944 |
Xylem Inc Stock (XYL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-26 | Initiated | William Blair | Outperform |
| Sep-19-25 | Initiated | Barclays | Overweight |
| May-30-25 | Initiated | JP Morgan | Overweight |
| Dec-12-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Dec-09-24 | Upgrade | Citigroup | Neutral → Buy |
| Sep-03-24 | Downgrade | TD Cowen | Buy → Hold |
| Aug-13-24 | Initiated | UBS | Buy |
| Mar-12-24 | Initiated | Exane BNP Paribas | Outperform |
| Jan-04-24 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-21-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-19-23 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-02-23 | Upgrade | Melius | Neutral → Overweight |
| Aug-29-23 | Initiated | Seaport Research Partners | Neutral |
| Jun-29-23 | Initiated | Deutsche Bank | Hold |
| Jun-08-23 | Resumed | Goldman | Buy |
| May-31-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-24-23 | Upgrade | Stifel | Hold → Buy |
| Jan-04-23 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Dec-19-22 | Downgrade | Stifel | Buy → Hold |
| Nov-16-22 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-18-22 | Upgrade | Cowen | Market Perform → Outperform |
| Aug-03-22 | Upgrade | Credit Suisse | Underperform → Neutral |
| Jul-20-22 | Upgrade | Stifel | Hold → Buy |
| Jul-15-22 | Initiated | Northcoast | Neutral |
| Jun-01-22 | Upgrade | Cowen | Market Perform → Outperform |
| Apr-05-22 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Jan-04-22 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Dec-17-21 | Initiated | Mizuho | Neutral |
| Nov-23-21 | Initiated | Loop Capital | Hold |
| Oct-01-21 | Downgrade | Rosenblatt | Buy → Neutral |
| Jun-18-21 | Initiated | Argus | Buy |
| May-05-21 | Upgrade | Goldman | Sell → Neutral |
| Mar-31-21 | Initiated | Morgan Stanley | Overweight |
| Jan-08-21 | Downgrade | Cowen | Market Perform → Underperform |
| Jan-08-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-15-20 | Downgrade | Stifel | Buy → Hold |
| Jul-14-20 | Upgrade | Rosenblatt | Neutral → Buy |
| May-15-20 | Upgrade | Vertical Research | Sell → Hold |
| Apr-16-20 | Downgrade | Vertical Research | Hold → Sell |
| Apr-08-20 | Downgrade | Goldman | Neutral → Sell |
| Mar-31-20 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Mar-27-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Mar-26-20 | Upgrade | Berenberg | Sell → Hold |
| Mar-23-20 | Downgrade | Boenning & Scattergood | Outperform → Neutral |
| Mar-10-20 | Downgrade | Credit Suisse | Neutral → Underperform |
| Feb-14-20 | Initiated | Rosenblatt | Neutral |
| Dec-17-19 | Initiated | Citigroup | Neutral |
| Dec-05-19 | Downgrade | Jefferies | Buy → Hold |
| Nov-04-19 | Downgrade | Seaport Global Securities | Buy → Neutral |
| Sep-20-19 | Initiated | Jefferies | Buy |
| Aug-02-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| May-14-19 | Downgrade | Cowen | Outperform → Market Perform |
| May-03-19 | Upgrade | Janney | Neutral → Buy |
| Mar-29-19 | Downgrade | Janney | Buy → Neutral |
| Dec-19-18 | Upgrade | Stifel | Hold → Buy |
View All
Xylem Inc Stock (XYL) Latest News
Oppenheimer Adjusts Xylem Price Target to $165 From $170, Maintains Outperform Rating - marketscreener.com
Xylem: Strong Quarter, But Weak Guidance (NYSE:XYL) - Seeking Alpha
Analysts Are Bullish on Top Industrial Goods Stocks: Xylem (XYL), GXO Logistics (GXO) - The Globe and Mail
RBC Capital Keeps Their Buy Rating on Xylem (XYL) - The Globe and Mail
Xylem (XYL) Is Down 9.3% After Cautious 2026 Guidance Despite Record 2025 Results And Dividend Hike - Yahoo Finance
Xylem Analysts Lower Their Forecasts After Q4 Results - Benzinga
Beyond The Numbers: 7 Analysts Discuss Xylem Stock - Benzinga
Xylem (XYL) Analyst Ratings: Stifel Lowers Price Target but Main - GuruFocus
RBC Capital Adjusts Price Target on Xylem to $162 From $176, Maintains Outperform Rating - marketscreener.com
Xylem (XYL): Analyst William Grippin Lowers Price Target to $156 | XYL Stock News - GuruFocus
Barclays Lowers Xylem (NYSE:XYL) Price Target to $156.00 - MarketBeat
Water Powerhouse at a Crossroads: A Deep Dive into Xylem Inc (XYL) in 2026 - FinancialContent
Stifel Adjusts Price Target on Xylem to $175 From $178, Maintains Buy Rating - marketscreener.com
XYL Q4 Deep Dive: Top-Line Headwinds as Strategy Shifts to Higher-Quality Revenue - Finviz
Xylem price target lowered to $175 from $178 at Stifel - TipRanks
Xylem Inc. (NYSE:XYL) Q4 2025 Earnings Call Transcript - Insider Monkey
Xylem Inc. $XYL is Impax Asset Management Group plc's 3rd Largest Position - MarketBeat
Xylem Q4 2025 slides: record performance overshadowed by cautious 2026 outlook - Investing.com South Africa
Xylem Q4 Earnings Call Highlights - MarketBeat
Xylem (NYSE:XYL) Surprises With Q4 CY2025 Sales - The Globe and Mail
Xylem shares slide after cautious 2026 outlook - MSN
We Expect Xylem's Smart Water Solutions to Drive Profitable Growth - Morningstar
Xylem Inc. Earnings Call Highlights Margin-First Strategy - TipRanks
Xylem Q4 profit jumps 20% on strong demand, provides upbeat 2026 outlook - AlphaStreet News
Xylem (NYSE:XYL) Earnings Steady as S&P 500 Context Highlights - Kalkine Media
Why Xylem (XYL) Stock Is Down Today - Finviz
Xylem Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Xylem Inc. (NYSE:XYL) Declares Quarterly Dividend of $0.43 - MarketBeat
Xylem Inc (XYL) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Transformation - GuruFocus
How Do Investors Really Feel About Xylem Inc? - Benzinga
Xylem (XYL) Reports Record Q4 Results and Sets Optimistic 2026 O - GuruFocus
Xylem (NYSE:XYL) Shares Gap DownWhat's Next? - MarketBeat
Xylem Inc. (NYSE:XYL) Not Lagging Market On Growth Or Pricing - 富途牛牛
Xylem (XYL) Shares Dip on 2026 Guidance Despite Strong Q4 - GuruFocus
Xylem Inc (XYL) Shares Down 5.49% on Feb 10 - GuruFocus
Xylem shares slide after cautious 2026 outlook (XYL:NYSE) - Seeking Alpha
Xylem (XYL) Q4 2025 Earnings Call Transcript - AOL.com
Xylem tops Q4 forecasts but strikes a cautious tone on 2026 - MSN
Earnings call transcript: Xylem Q4 2025 posts solid earnings, stock dips - Investing.com
RBC Capital reiterates Outperform rating on Xylem stock after mixed results - Investing.com
RBC Capital reiterates Outperform rating on Xylem stock after mixed results By Investing.com - Investing.com India
Xylem forecasts downbeat 2026 on weak demand for water-treatment equipment - marketscreener.com
Compared to Estimates, Xylem (XYL) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
Xylem Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Xylem Inc (NYSE:XYL) Tops Q4 Earnings Estimates but Cautious 2026 Outlook Weighs on Shares - ChartMill
Xylem Inc. Declares First-Quarter Dividend, Payable on March 24, 2026 - marketscreener.com
Xylem Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
Xylem: Q4 Earnings Snapshot - kens5.com
Xylem (XYL) Q4 Earnings Meet Estimates - Yahoo Finance
Xylem: Fourth Quarter Earnings Overview - Bitget
Xylem's Q4 Adjusted Earnings, Revenue Increase; 2026 Outlook Issued - marketscreener.com
Xylem Inc Stock (XYL) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.61%
2.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):